Inotek Pharmaceuticals

Inotek Pharmaceuticals

Inotek Pharmaceuticals

Inotek Pharmaceuticals develops drug candidates to address significant diseases of the eye.
Founded
1996
Raised
$69.9M
Follow us
Alexa global traffic share
Latest funding Show all
$7,000,000
Debt financing - 2013
$23,600,000
Venture capital (Series D) - 2011
Team Size
1–10
Employees
The Motley Fool

Why Inotek Pharmaceuticals Corporation Stock Rose 28.4% in April